1. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors. Issue 9 (17th September 2015) Authors: Canning, Peter; Ruan, Qui; Schwerd, Tobias; Hrdinka, Matous; Maki, Jenny L.; Saleh, Danish; Suebsuwong, Chalada; Ray, Soumya; Brennan, Paul E.; Cuny, Gregory D.; Uhlig, Holm H.; Gyrd-Hansen, Mads; Degterev, Alexei; Bullock, Alex N. Journal: Chemistry & biology Issue: Volume 22:Issue 9(2015) Page Start: 1174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases. (23rd January 2014) Authors: Canning, Peter; Bullock, Alex N. Journal: Biochemical Society transactions Issue: Volume 42:Number 1(2014) Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗